Sanofi-Aventis Dealt A Setback
Sanofi-Aventis was dealt a blow in its attempt to prevent a generic version of its popular anti-clotting drug Lovenox when a U.S. District Court judge ruled that the drug maker was...To view the full article, register now.
Already a subscriber? Click here to view full article